Emerging therapies for type 2 diabetes: GLP-1 receptor agonists and DPP-4 inhibitors
Researchers looked at participants health records to see if colorectal cancer was diagnosed after starting either a GLP-1 or aspirin
The Phase 3 TRIUMPH program will determine whether, and at what doses, retatrutide reaches the market
There is, however, a class of medications known as GLP-1 agonists, which a medical professional may consider in the treatment of diagnosable diseases such as Type 2 diabetes
If abdominal injections make you anxious, if looking at the needle going into your stomach triggers dread, then the thigh is your best site regardless of what the pharmacokinetic data says
Experts caution that combining these unregulated supplements with prescription medications could lead to potentially dangerous side effects, particularly for individuals managing diabetes